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HAVEL, PETER J., THOMAS L. PAQUETTE,AND GERALD J. 
TABORSKY, JR. Halothane is less suppressive than pentobarbital 
on reflex and neural activation of pancreatic F-cell. Am. J. 
Physiol. 251 (Endocrinol. Metab. 14): Elll-E116, 1986.-To 
determine the suitability of halothane anesthesia for studies of 
parasympathetic control of the endocrine pancreas in dogs, we 
assessed the effect of halothane on reflex, direct neural, and 
direct chemical activation of the parasympathetic input to the 
islet. Levels or output of pancreatic polypeptide (PP), an islet 
hormone under predominant cholinergic influence, were used 
as an indicator of the degree of parasympathetic activation and 
its potential suppression by anesthesia. Reflex stimulation of 
the parasympathetic nervous system by 2-deoxy-D-glucose (2- 
DG) in dogs anesthetized with halothane (0.8%) caused a 
fourfold increase in plasma PP levels, equivalent to the re- 
sponse in conscious dogs. In contrast, 2-DG at this dose and at 
a threefold higher dose did not alter PP levels in dogs anesthe- 
tized with pentobarbital (30 mg/kg iv), suggesting that halo- 
thane at this dose is not suppressive and that pentobarbital is 
very suppressive on reflex activation of the parasympathetic 
nerves to the pancreas. Bilateral electrical stimulation of the 
cervical vagi in halothane-anesthetized dogs elicited a sixfold 
increase in the pancreatic output of PP. The same stimulation 
caused only a twofold increase of PP output in pentobarbital- 
anesthetized dogs. These data suggests that halothane is also 
less inhibitory than pentobarbital on either peripheral neuro- 
transmission or pancreatic F-cell responsiveness. The effect of 
direct activation of the F-cell by bethanechol did not differ 
between the two anesthesias. Therefore, the attenuated PP 
response to vagal stimulation in pentobarbital-anesthetized 
dogs is probably due to an action of pentobarbital on peripheral 
neurotransmission, perhaps at the intrapancreatic parasympa- 
thetic ganglia. Together these data suggest that halothane is a 
more suitable anesthetic than pentobarbital for use in animal 
experiments studying reflex or electrical activation of the para- 
sympathetic input to the pancreatic F-cell. 
pancreatic polypeptide; 2-deoxy-D-glucose; neuroglucopenia; 
vagal nerve stimulation; bethanechol; parasympathetic nervous 
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WE HAVE RECENTLY SHOWN that pentobarbital anesthe- 
sia abolishes reflex activation of the parasympathetic 
input to the pancreas in dogs (17). This action of pen- 
tobarbital could lead to a serious underestimation of the 
parasympathetic contribution to certain pancreatic en- 
docrine and exocrine responses. In addition, our difficul- 
ties in demonstrating a pancreatic response to electrical 
stimulation of the vagi led us to suspect that pentobar- 
bital may also suppress peripheral activation of the para- 
sympathetic input to the pancreas. These documented 
and potential problems with the inhibition of parasym- 
pathetic events by pentobarbital led us to evaluate halo- 
thane. Halothane has been demonstrated to be less sup- 
pressive than pentobarbital on certain cardiovascular 
reflexes that have parasympathetic components (5). Our 
aim was to determine whether halothane at a dose pro- 
viding surgical anesthesia would be less suppressive than 
pentobarbital on central and/or peripheral activation of 
the parasympathetic input to the pancreas. 
For the purpose of evaluating the degree of parasym- 
pathetic activation we measured pancreatic polypeptide 
in plasma. Recent studies suggest that the level of pan- 
creatic polypeptide (PP) in plasma may reflect parasym- 
pathetic neural input to the pancreas. For example, va- 
gotomy or ‘atropine reduces basal PP levels (17) and the 
PP response to a meal (9,16). Vagotomy or atropine also 
reduce the PP responses to reflex activation of the para- 
sympathetic nervous system produced by insulin-induced 
hypoglycemia (10, 13) or by 2deoxy-D-glucose-induced 
(2-DG) neuroglucopenia (8, 17). 
To test whether halothane is less suppressive than 
pentobarbital on reflex activation of the parasympathetic 
nervous system, we measured the plasma PP response to 
2DG in dogs anesthetized with halothane and compared 
it with our previously measured responses in conscious 
dogs and in dogs anesthetized with pentobarbital. 
To determine whether halothane is less suppressive 
than pentobarbital on peripheral parasympathetic neu- 
rotransmission, we compared the PP response to electri- 
cal stimulation of the cervical vagi in dogs anesthetized 
with halothane to that in dogs anesthetized with pento- 
barbital. 
Finally, to determine the effect of halothane directly 
on the pancreatic F-cell, we compared the plasma PP 
response to the injection of the acetylcholine analogue 
bethanechol in halothane-anesthetized dogs to the re- 
sponse we previously observed in pentobarbital-anesthe- 
tized dogs. 
MATERIALS AND METHODS 
Animals and surgical procedures. Thirty-two dogs of 
mixed breed weighing 19-46 kg were used in the chronic 
experiments with halothane anesthesia and in the vagal 
nerve stimulation experiments. Seventeen other t dogs 
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were used in the previously reported chronic experiments 
in conscious or pentobarbital-anesthetized dogs. Data 
from these animals are included in Table 1 and in Figs. 
1, 2, and 5 for comparison with the halothane experi- 
ments. All animals were fasted overnight (-18 h) before 
the experiments were started. 
A total of 22 experiments were performed in the 10 
dogs used in the experiments with 2-DG or bethanechol. 
They were implanted with chronic catheters in the tho- 
racic aorta. For this purpose, dogs were anesthetized with 
methoxyflurane and a right lateral thoracotomy was 
performed. The descending thoracic aorta was cannu- 
lated with a 16-gauge Teflon catheter, which was then 
secured to the external aortic wall with 4-O Teflon- 
polyester suture. The catheter was then glued to 100 cm 
of heparin-loaded polyvinyl tubing, which was routed via 
a subcutaneous tunnel to an incision site dorsal to the 
thoractomy. The thoracotomy incision was closed and 
the dogs were fitted with a nylon jacket (Alice Chatham, 
Los Angeles, CA) containing a zippered pocket to hold 
the coiled external catheter tubing when not in use. The 
catheters were flushed with heparin solution and checked 
for patency three times weekly. The dogs were allowed 
at least 3 days recovery after surgery before the experi- 
ments were performed. 
A total of 29 experiments were performed in the 22 
dogs in which the cervical vagi were electrically stimu- 
lated. The dogs were anesthetized either with halothane 
(0.8% inspired concentration in oxygen) after sodium 
thiamylal induction or with a bolus of pentobarbital 
sodium (30 mg/kg, iv) followed by an infusion of 0.05 to 
0.2 mg l kg-’ l min. All dogs were mechanically venti- 
lated. A midline laparotomy was performed, and an ex- 
tracorporeal blood flow circuit was established. The su- 
perior pancreatic-duodenal yein (SPDV) was isolated 
and cannulated with a Silastic catheter that routed blood 
through an electromagnetic flowmeter past a sampling 
port and into the portal vein (18). Anticoagulation was 
maintained by an infusion of heparin (30 U/min) into 
the SPDV end of the circuit. The femoral artery and vein 
were also cannulated. Blood was sampled from the artery 
and the mean arterial blood pressure and heart rate were 
monitored by means of a pressure transducer. Normal 
saline (0.9%) was infused slowly into the femoral vein 
during the surgery and the experiment. 
After the abdominal procedures, the right and left 
branches of the cervical vagi were isolated from the fascia 
adjacent to the common carotid arteries. The vagal 
trunks were cut between two ligatures, and the distal 
part of each was connected to an electrode (Harvard 
Apparatus, South Natick, MA). The experiments were 
performed 1 h after these procedures. 
Protocol. To determine the effect of halothane anes- 
thesia on reflex activation of the parasympathetic input 
to the pancreas, dogs bearing chronic catheters were 
administered 2-deoxy-D-glucose (2DG). Anesthesia was 
first induced with 18 mg/kg intravenous (iv) thiamylal 
sodium (Surital, Parke Davis, Morris Plains, NJ), an 
ultra short-acting barbiturate. The trachea was intubated 
and the animal was ventilated with an air-driven res- 
pirator connected to a vaporizer (Draeger, West Ger- 
many) supplying 0.8% halothane (inspired concentra- 
tion) in oxygen. At least 45 min was allowed for the 
barbiturate to be redistributed and for thorough halo- 
thane induction before a base-line sample was drawn. 
The 2-DG was administered as a bolus of 100 or 300 mg/ 
kg and flushed in rapidly with saline. Blood samples were 
drawn from the chronically implanted catheter at 5, 15, 
30,45, 50, and 60 min after the 2-DG injection. 
To evaluate the effects of halothane or pentobarbital 
anesthesia on peripheral neurotransmission in the oper- 
ated dogs, we measured the PP response to bilateral 
electrical stimulation of the cervical vagi. The vagal 
nerves were stimulated for 10 min with square-wave 
pulses of 5 ms duration and 13.5 mA current at a fre- 
quency of 10 Hz. The stimulations were performed with 
a Grass model S-44 stimulator with a Grass PSIUG 
constant current stimulus isolation unit (Grass Instru- 
ments, Quincy, MA). Blood samples from both the fem- 
oral artery (FA) and from SPDV were drawn at -5 and 
0 min before, at 5 and 10 min during, and 5 and 10 min 
after the stimulation. Blood flow in the SPDV was mea- 
sured with an electromagnetic square-wave flowmeter 
(Zepeda Instruments, Seattle, WA, model SWF-4RD). 
Hematocrit was determined at regular intervals through- 
out the experiments. 
To assess the effect of halothane anesthesia on direct 
chemical activation of the pancreatic F-cell, halothane- 
anesthetized dogs bearing chronic catheters were injected 
with the acetylcholine analogue bethanechol (Urecho- 
line, Merck Sharp & Dohme, West Point, PA) at a dose 
of 100 pg/kg iv. Blood samples were drawn at -5 and 0 
min before and at 2, 3,4, 5, 10, 15, and 30 min after the 
bethanechol injection. 
Assays and data analysis. Blood samples for pancreatic 
polypeptide (PP) were drawn and put into tubes contain- 
ing EDTA and placed on ice; immediately after the 
experiments the blood samples were centrifuged at 4°C 
for 20 min. Plasma was separated and frozen at -20°C 
until assayed. Plasma PP was measured by a radioim- 
munoassay using on antibody similar to that developed 
by Chance (4) and a tracer of 12?-porcine PP. 
The changes of systemic plasma concentrations of PP 
in response to 2-DG were calculated by subtracting the 
0-min value from the 15-min value after the injection of 
2-DG. The 0- to 60-min integrated response is expressed 
as an incremental area under the PP-time curve (in pg. 
min-l -ml-l). 
The changes of FA and SPDV plasma PP concentra- 
tions during vagal nerve stimulation were calculated by 
subtracting the mean of the two base-line samples from 
the mean of the 5- and lo-min values. The output of PP 
from the right lobe of the pancreas in picograms per 
minute was calculated as follows: [ (PP)SPDV - (PP)FA] 
x blood flow x (1 - hematocrit). 
The changes of systemic plasma PP concentration in 
response to bethanechol were calculated by subtracting 
the mean of the -5- and 0-min values from the 5-min 
value following bethanechol injection. The integrated PP 
response to bethanechol was calculated as the incremen- 
tal area under the PP-time curve (in pg. min. ml-‘), for 
the 10 min following the injection of bethanechol. 
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The data are reported in the RESULTS as means t SE. 
Statistical comparisons of means within a group were 
made with a paired t test; statistical comparisons of 
means of different groups were made with a two-sample 
t test. 
RESULTS 
PP response to 2-DG (100 mglkg) in halothane-anes- 
thetized dogs. In dogs anesthetized with halothane 
(0.8%), base-line PP averaged 192 t 35 pg/ml in systemic 
plasma. PP increased to 760 t 218 pg/ml by 15 min after 
the injection of 100 mg/kg of 2DG (A = 568 t 208 pg/ 
ml; P < 0.025). PP remained at this level for the l-h 
observation period after the Z-DG injection (Fig. 1). The 
incremental area under the PP-time curve (O-60 min) 
was 24,072 t 9,417 pg*minml-’ (P c 0.025). These data 
are compared with the previously reported data (17) 
obtained from pentobarbital-anesthetized or conscious 
dogs given in Table 1. The PP response to 2-DG (100 
mg/kg) was significantly greater in halothane-anesthe- 
tized dogs than in pentobarbital-anesthetized dogs (P < 
0.025; Fig. 1). Neither the basal nor 2-DG stimulated PP 
levels in conscious dogs were significantly different from 
those of the halothane-anesthetized dogs (Fig. 1). 
PP response to 2-DG (300 mg/kg) in halothane-anes- 
thetized dogs. In a second set of experiments dogs were 
anesthetized with halothane (0.8%). Basal concentra- 
tions of PP were 367 t 160 pg/ml. PP increased to 1,180 
t 297 pg/ml by 15 min after the injection of 300 mg/kg 
of 2-DG, an increase of 813 t 195 pg/ml (P < 0.005). 
The 0- to 60-min incremental area under the PP-time 
curve was 29,383 t 5,732 pg~minml-’ (P < 0.0025). 
These data are compared with the previously reported 
data (17) obtained from pentobarbital-anesthetized dogs 
given in Table 1. The PP response to this increased dose 
of 2-DG in halothane-anesthetized dogs was significantly 
larger than that in pentobarbital-anesthetized dogs 
whether expressed as the peak response 15 min after the 
2-DG 
(lOOmg/kg IV) 
v 
c+EJs = 
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T 
Pentobarbital 
n=7 
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FIG. 1. Change of plasma pancreatic polypeptide (PP) in response 
to Z-deoxyglucose (2-DG; 100 mg/kg iv) in 8 dogs anesthetized with 
halothane (0.8%), in 7 dogs anesthetized with pentobarbital (30 mg/ 
and in 7 unanesthetized dogs. 
2-DG (P < 0.0005) or as an incremental area (P < 0.0005; 
Fig. 2). 
In conscious dogs, a dose of 300 mg/kg of 2-DG caused 
convulsions that were quickly terminated by pentobar- 
bital injection. Therefore the comparable PP data from 
conscious dogs are not available. 
Comparison of the PP responses to bilateral cervical 
vagal nerve stimulation in halothane-anesthetized and 
pentobarbital-anesthetized dogs. Arterial concentrations 
of PP in operated dogs anesthetized with halothane 
(0.8%) were 282 t 103 pg/ml. Arterial PP increased to 
749 t 135 pg/ml (the mean of 5- and lo-min points) 
during electrical stimulation of the cervical vagi (A = 
467 t 108 pg/ml; P c 0.0025). 
In dogs anesthetized with pentobarbital (30 mg/kg + 
0.05 - 0.2 mg= kg-’ . min-‘), the basal arterial PP concen- 
tration was 527 t 50 pg/ml. In response to vagal nerve 
stimulation, arterial PP increased to 731 t 82 pg/ml ( A 
= 204 t 44 pg/ml; P c 0.00025). The increase of arterial 
PP in response to electrical stimulation of the vagus 
nerves was greater in halothane-anesthetized dogs than 
in pentobarbital-anesthetized dogs (P < 0.025; Fig. 3). 
In dogs anesthetized with halothane, basal PP output 
(see MATERIALS AND METHODS) from the right lobe of 
the pancreas was 4,186 t 2,157 pg/min. PP output in- 
creased to a mean of 29,634 t 5,520 pg/min at the 5- and 
lo-min time points during nerve stimulation, an incre- 
ment of 25,448 & 5,243 pg/min (P < 0.0025). 
In pentobarbital-anesthetized dogs basal PP output 
was 7,301 t 1,392 pg/min. During vagal nerve stimula- 
tion PP output increased to 15,972 t 4,166 pg/min, an 
increase of 8,671 t 3,398 pg/min (P < 0.025). 
The increase of PP output during electrical stimulation 
of the cervical vagi was significantly larger in the dogs 
anesthetized with halothane than in the dogs anesthe- 
tized with pentobarbital (P < 0.005; Fig. 4). 
PP response to bethanechol injection in halothane- 
anesthetized dogs. Basal concentrations of PP in the 
arterial plasma of halothane-anesthetized dogs averaged 
247 t 29 pg/ml. PP increased to a concentration of 583 
+ 49 pg/ml 5 min after the intravenous injection of 100 - 
pg/kg of bethanechol, an increase of 336 t 52 pg/ml 
(P < 0.0005). The incremental PP response expressed 
an area under the PP-time curve from 0 to 10 min was 
2,550 t 415 pgominml-’ (P < 0.0005). These data are 
compared with the previously reported data (17) obtained 
from pentobarbital-anesthetized dogs given in Table 1. 
The PP response to bethanechol in the halothane-anes- 
thetized dogs was not significantly different from that in 
the pentobarbital-anesthetized dogs, whether expressed 
as a peak 5-min response or as an integrated total 0- to 
lo-min area response (Fig. 5). 
DISCUSSION 
In the present studies we sought to determine whether 
a dose of halothane producing surgical anesthesia sup- 
presses parasympathetic outflow to the pancreas. To this 
end we compared the effects of reflex activation, pregan- 
glionic electrical activation, and direct chemical activa- 
tion of the cholinergic input to the pancreas in dogs 
El14 HALOTHANE ON PANCREATIC POLYPEPTIDE 
TABLE 1. Effects of halothane and pentobarbital on PP responses to Z-DG and bethanechol 
-__- 
2-DG (100) 2-DG (300) Bethanechol 
Stimulus 
~---. 
Halo Pento* Cons* Halo Pento* Halo Pento* 
(8) (7) (7) (6) (7) (8) (6) 
Basal [PP], pg/ml 192t35 145*15 233&55 367&160 186t13 247t29 183t29 
mw9 P@l 568&208 -2t13t 676t249 813*195 13+13$ 336t52 5241U87 
PP Area, pg. min. ml-’ 24,072+9,147 -267iz588t 23,991+8,787 29,383+5,732 -9&399$ 2,550-r-415 3,670+1,261 --- 
Values are means t SE. Halo, halothane anesthesia (0.8%); Pento, pentobarbital anesthesia (30 mg/kg iv); Cons, conscious, no anesthe- 
sia. * Previously published data included for the purpose of comparison with halothane data. t P c 0.025 vs. halothane. $ P < 0.0005 VS. 
halothane. 
2-DG 
(300mg/kg IV) 
b-4 
I VAGAL STIM. HaFt;$e 
8009 
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FIG. 2. Change of plasma pancreatic polypeptide (PP) in response z 
to 2deoxyglucose (2-DG; 300 mg/kg iv) in 6 dogs anesthetized with 
halothane (0.8%) and in 7 dogs anesthetized with pentobarbital (30 
piGi--1 HZiFe 
I I I 
1 
-5 0 
1 
10/o 10 
I 
PenS+l 
Minutes 
FIG. 4. Change of pancreatic polypeptide (PP) output (see MATE- 
RIALS AND METHODS) in response to bilateral cervical vagal nerve 
stimulation (10 Hz, 5 ms, 13.5 mA) in 13 dogs anesthetized with 
halothane (0.8%) and in 16 dogs anesthetized with pentobarbital (30 
mdkd l 
anesthetized with halothane with those in dogs anesthe- 
750. 
tized with pentobarbital. When appropriate, we com- 
pared the effects with those observed in conscious dogs. 
However, to determine the magnitude of the activation, 
it is necessary to have a reliable measurement of the 
parasympathetic input to the pancreas. Because the 
parasympathetic neurotransmitter, acetylcholine, is rap- 
idly eliminated from plasma by acetylcholinesterase, its 
use as an indicator of parasympathetic neural activity is 
precluded. One alternative, the measurement of plasma 
pancreatic polypeptide levels, is useful for two reasons. 
First, pancreatic polypeptide is specific to the pancreas 
I and therefore its levels will reflect parasympathetic input 
I 1 1 1 
-5 0 10/o 10 
to the pancreas even when this differs from general 
Minutes 
parasympathetic outflow. Second, PP secretion appears 
FIG. 3. Change of plasma pancreatic polypeptide (PP) in response 
to be predominantly under cholinergic control. For ex- 
to bilateral cervical vagal nerve stimulation (10 Hz, 5 ms, 13.5 mA) in ample, atropine or vagotomy blocks the PP response to 
13 dogs anesthetized with halothane (0.8%) and 16 dogs anesthetized a meal (9, 16), to insulin-induced hypoglycemia (10, 13), 
with pentobarbital (30 mg/kg). and to Z-DG-induced central neuroglucopenia (3, 8, U’), 
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FIG. 5. Change of plasma pancreatic polypeptide (PP) in response 
to bethanechol (100 mg/kg iv) in 8 dogs anesthetized with halothane 
(0.8%) and in 6 dogs anesthetized with pentobarbital (30 mg/kg). 
all presumably reflexively mediated events. In addition, 
combined adrenergic blockade does not influence the PP 
response to insulin-induced hypoglycemia (12). Atropine 
also blocks the PP response to either electrical stimula- 
tion of the vagi (3, 13) or to chemical muscarinic stimu- 
lation with bethanechol (16). Further, reports that 
graded doses of acetylcholine and graded electrical stim- 
ulations of the vagus nerves produce proportional in- 
creases of plasma PP (13) suggest that the level of PP in 
plasma might be used as an index of the degree of 
parasympathetic cholinergic input to the pancreas. 
Therefore, in the present study we have assessed the 
effect of halothane anesthesia on parasympathetic input 
to the pancreas by measuring the PP response to reflex, 
electrical, and chemical activation of the pancreatic F- 
cell. 
A dose of 0.8% (inspired concentration) was chosen 
because this was the highest level that has been shown 
to allow cardiovascular responses of conscious magnitude 
in dogs (1). Other doses of halothane were not studied 
because our goal was consistent surgical anesthesia with- 
out parasympatholytic effects. 
The PP response to reflex activation of the parasym- 
pathetic nervous system by Z-DG in halothane-anesthe- 
tized dogs was not significantly different from the re- 
sponse observed in unanesthetized dogs and clearly larger 
than that in pentobarbital-anesthetized dogs who had no 
measurable PP response to this dose of Z-DG (17). A 
threefold higher dose of Z-DG exaggerated the difference 
between anesthesias because it produced a larger PP 
response in the halothane-anesthetized dogs and still no 
measurable PP response in pentobarbital-anesthetized 
dogs. Taken together, these data suggest that halothane 
anesthesia does not suppress the reflex activation of the 
parasympathetic input to the pancreas and is therefore 
superior to pentobarbital anesthesia for this type of 
study. 
Next we investigated the possibility that halothane 
might also be superior to pentobarbital for studies of the 
effects of electrical stimulation of the vagal nerves to the 
pancreas. This possibility was suggested by our own 
difficulties in producing a PP response to vagal nerve 
stimulation in dogs anesthetized with pentobarbital and 
by the known effects of barbiturates to inhibit synaptic 
transmission (7). We measured the PP response to elec- 
trical stimulation of the cervical vagi in dogs anesthetized 
with halothane and compared the response with that 
measured in dogs anesthetized with pentobarbital. The 
increment of arterial PP was significantly larger in dogs 
anesthetized with halothane. The increment of PP out- 
put was also significantly larger. This demonstrates that 
the larger charge of peripheral PP reflects a true increase 
in the rate of PP secretion and not a differential effect 
of the anesthesias on PP clearance. These results indi- 
cate that, while pentobarbital anesthesia does not abolish 
the PP response to electrical stimulation of the vagus 
nerves, it nonetheless is suppressive when compared with 
halothane anesthesia. 
The suppressive effect of pentobarbital on the PP 
response to vagal nerve stimulation could be due to an 
action either on the vagal nerves and associated ganglia 
or on the pancreatic F-cell directly. To determine 
whether the attenuated PP response to vagal stimulation 
is due to an effect of pentobarbital on the F-cell, we 
measured the PP response to the intravenous injection 
of bethanechol in halothane-anesthetized dogs and com- 
pared it with the responses observed in pentobarbital- 
anesthetized dogs. The PP response to bethanechol in 
pentobarbital-anesthetized dogs was equivalent to that 
in halothane-anesthetized dogs. Thus the smaller PP 
response to vagal stimulation seen in pentobarbital-anes- 
thetized dogs does not appear to be due to an inhibitory 
effect directly on the F-cell but rather to an inhibitory 
effect of pentobarbital on peripheral parasympathetic 
neurotransmission. One likely site of this inhibitory ac- 
tion is the intrapancreatic parasympathetic ganglia. Bar- 
biturates are known to suppress neurotransmission 
across sympathetic ganglia (7) and there are reports of 
the same effect on parasympathetic ganglia (15). 
Although the data presented here suggest that halo- 
thane is superior to pentobarbital for the preservation of 
parasympathetic responses, other studies of the effect of 
halothane show progressive suppression of cardiovascu- 
lar reflexes in proportion to the concentration of halo- 
thane administered (1). It is important to recognize that 
the difference between halothane and pentobarbital may 
be less marked at a higher concentration of halothane. 
The level of halothane (0.8% inspired concentration) 
used in the present study is less than that established to 
produce surgical anesthesia in dogs. An expired concen- 
tration of 0.87% is reported to be the minimum alveolar 
concentration necessary to prevent movement in 50% of 
dogs in response to noxious stimuli (11). Yet in our 
experience, 0.8% inspired halothane has produced sur- 
gical anesthesia in over 90% of the cases. We believe 
that this reduced halothane requirement is due to our 
use of thiamylal induction. Indeed, induction with thio- 
pental, a very similar short-acting barbiturate, does re- 
duce minimum alveolar concentration in dogs (6). It is 
possible that 0.8% inspired halothane would not produce 
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surgical anesthesia in dogs induced with halothane alone. 
In summary, ha .lothane does not suppress the PP 
response to Z-DC, suggesting little, if any, suppression 
of the reflex activation of parasympathetic outflow to 
the pancreas. This reflex is markedly suppressed by 
pentobarbital (17). Halothane is also less suppressive 
than pentobarbital on the PP response to electrical stim- 
ulation of the cervical vagi, su .ggesting tha t pentoba .rbital 
inhibits parasympathetic neurotransmission, perhaps bY 
inhibiting synaptic trans mission in the intrapancrea .tic 
parasympathetic ganglia. Thus, for experiments studying 
the effects of either reflex or electrical parasympathetic 
activation of the pancreatic F-cell, halothane anesthesia 
appears to be superio r to pentobarbital. Alth .ough these 
interpretation .s of the data are confined to the pancreatic 
polypeptide response, they may well be applicable to the 
parasympathetic components of other physiological re- 
8. 
9. 
10. 
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None of the data from the experiments with halothane anesthesia 
or the nerve stimulation experiments with pentobarbital anesthesia 
have been presented before, even in abstract form. Some data from 
experiments in pentobarbital-anesthetized or conscious dogs in Table 
1 and in Figs. 1,2, and 5, which are included for purposes of comparison 
with the halothane data, are from Ref. 17. 
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